MDxHealth Maintains Its Previously Issued 2024 Revenue Guidance Of $79M-$81M (Est $79.629M); Confirms Its View Of Expected Adjusted EBITDA Profitability In H1'2025
Portfolio Pulse from Benzinga Newsdesk
MDxHealth has reaffirmed its revenue guidance for 2024, projecting revenues between $79M and $81M, aligning with the estimated $79.629M. The company also confirmed its expectation to achieve adjusted EBITDA profitability in the first half of 2025.
March 06, 2024 | 9:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MDxHealth confirms its 2024 revenue guidance of $79M-$81M and expects adjusted EBITDA profitability by H1'2025.
Reaffirming revenue guidance and setting clear profitability expectations can positively influence investor confidence and potentially lead to an increase in stock price in the short term. The specificity of the guidance and the timeline for profitability provide clear benchmarks for investors to track the company's performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100